Don’t forget you can visit MyAlerts to manage your alerts at any time.
Pharmaceuticals
-
Goodwin Enlisted for $1.15 Billion GSK Acquisition of US Biopharma Business
By Jack Womack | January 14, 2025
The acquisition of the cancer specialist company was announced on the London Stock Exchange.
1 minute read
-
Trump and Latin America: Lawyers Brace for Hard-Line Approach to Region
By Amy Guthrie | November 26, 2024
The incoming president has already threatened to impose high tariffs on imports from Mexico, prompting a response from Mexico's president that hints at a potential trade war. Latin America and the Caribbean are likely to become more of a focus for the U.S. under the second Trump administration, lawyers say.
1 minute read
-
Simpson Thacher and Davis Polk bag lead roles on AstraZeneca's $2.7bn US pharma acquisition
By Vern Pitt | November 9, 2015
UK pharmaceutical giant turns to US firm as it buys kidney disease treatment maker ZS Pharma amid booming M&A market
1 minute read
-
Slaughters and Sullivan & Cromwell among firms advising as Shire buys Dyax for $5.9bn
By Anna Ward | November 2, 2015
Firms win roles in latest pharma deal as UK-listed Shire moves to buy US biotech group Dyax
1 minute read
-
Slaughters and Sullivan & Cromwell among firms advising as Shire buys Dyax for $5.9bn
By Anna Ward | November 2, 2015
Firms win roles in latest pharma deal as UK-listed Shire moves to buy US biotech group Dyax
1 minute read
-
Latham and Simpson Thacher advise on $8bn science real estate buyout
By Rose Walker | October 9, 2015
US duo take lead roles as Blackstone Group agrees to buy medical real estate company BioMed Realty Trust
1 minute read
-
Latham and Simpson Thacher advise on $8bn science real estate buyout
By Rose Walker | October 9, 2015
US duo take lead roles as Blackstone Group agrees to buy medical real estate company BioMed Realty Trust
1 minute read
-
Clifford Chance and Sullivan & Cromwell lead on $3.5bn pharma deal
By James Booth | September 9, 2015
Clifford Chance and Sullivan & Cromwell lead as Cinven sells Amdipharm Mercury
1 minute read
-
US firms monopolise pharma deals as market swells
By Rose Walker | September 8, 2015
US firms dominate as pharma sector booms, with 2015 seeing some of the biggest deals of the last three years
1 minute read
-
US firms monopolise pharma deals as market swells
By Rose Walker | September 8, 2015
US firms dominate as pharma sector booms, with 2015 seeing some of the biggest deals of the last three years
1 minute read
-
2 Law Firms Disqualified Over Litigation Funding
By Charles Toutant | February 3, 2025
The ruling serves as a reminder of the ethical questions that can arise when litigants accept funds from nonparties who are willing to pay the bills.
1 minute read
-
Ozempic Defendants Seek to Shave 'Tacked On' Claims From MDL Complaint
By Aleeza Furman | January 27, 2025
Novo Nordisk and Eli Lilly's motion to dismiss took aim at most of the counts asserted in the plaintiffs’ master long-form complaint, however the defendants are saving their challenge to certain claims for later.
1 minute read
-
Plaintiff Argues Jury's $22M Punitive Damages Finding Undermines J&J's Talc Trial Win
By Aleeza Furman | January 22, 2025
The plaintiff filed a motion for a new trial, arguing that, “At a minimum, the verdict shows confusion and lack of understanding of the issues or instructions.”
1 minute read
-
Indiana AG Accuses Big Pharma of Inflating EpiPens Price by 600%, Lawsuit Says
By Colleen Murphy | January 22, 2025
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.
1 minute read
-
FTC Launches Inquiry of Single-Family Rental Home 'Mega Investors,' Issues PBM Report
By Chris O'Malley | January 15, 2025
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify due to complicated, indirect ownership structures involving opaquely named subsidiary entities," said FTC attorney Tamar Katz.
1 minute read
-
Delaware Business Court Insider
Defending Against a $290M Claim and Scoring a $116M Win in Del. Drug Patent Fight
By Ross Todd | January 15, 2025
A trial team led by Latham’s Mike Morin and David Frazier and Finnegan’s William (Bill) Raich helped Sarepta Therapeutics come out victorious as the counter-claimant in a patent trial concerning treatment for Duchenne Muscular Dystrophy, a degenerative muscular disorder.
1 minute read
-
NJ Firm Narrowly Avoids Case Dismissal Over Lengthy Complaint Filed in Fed Court
By Colleen Murphy | January 13, 2025
“The content of the amended complaint from page 53 to page 71 is just concise and direct enough to avoid violating Rule 8,” U.S. District Judge John A. Ross said.
1 minute read
-
Plaintiff Narrowly Avoids Dismissal Over Lengthy Complaint Filed in Federal Court
By Colleen Murphy | January 13, 2025
“The content of the amended complaint from page 53 to page 71 is just concise and direct enough to avoid violating Rule 8,” U.S. District Judge John A. Ross said.
1 minute read
-
AstraZeneca Files Flurry of Lawsuits to Protect Cancer Treatment Drug
By Colleen Murphy | January 10, 2025
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.
1 minute read
-
'Discordant Dots': Why Phila. Zantac Judge Rejected Bid for His Recusal
By Aleeza Furman | January 9, 2025
In a footnote of his opinion, Judge Joshua Roberts wrote, “A more cynical view of the circumstances is that plaintiffs’ counsel used the motion as a broadside against my oversight of the entire mass torts program.”
1 minute read
More From ALM
With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas.
View Now
View Now
Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team.
View Now
View Now
Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same.
View Now
View Now
Dynamically explore and compare data on law firms, companies, individual lawyers, and industry trends.
Law.com Compass includes access to our exclusive industry reports, combining the unmatched expertise of our analyst team with ALM’s deep bench of proprietary information to provide insights that can’t be found anywhere else.
Law.com Compass delivers you the full scope of information, from the rankings of the Am Law 200 and NLJ 500 to intricate details and comparisons of firms’ financials, staffing, clients, news and events.
March 24, 2025
New York, NY
Learn More
New York, NY
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Learn More
March 24, 2025 - March 27, 2025
New York, NY
Learn More
New York, NY
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Learn More
November 26, 2025
London
Learn More
London
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Learn More
Our client, a thriving personal injury firm known for its commitment to compassionate client care is seeking an attorney with 5+ years of ex...
Apply Now ›
McCarter and English s Chambers-ranked Government Contracts group is seeking an experienced, diligent, and proactive government contracts as...
Apply Now ›
The Court of Appeal, First Appellate District in San Francisco is accepting applications for a central staff attorney vacancy. A regular ful...
Apply Now ›